Structure based modeling of small molecules binding to the TLR7 by atomistic level simulations

Molecules

Volumn 20, Issue 5, 2015, Pages 8316-8340

  Gentile, Francesco ^a   Deriu, Marco A ^b   Licandro, Ginevra ^b   Prunotto, Alessio ^b   Danani, Andrea ^b   Tuszynski, Jack A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF APPLIED SCIENCES AND ARTS OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

Adenine derivatives; Homology modeling; Imidazoquinoline; Immune system; Molecular docking; Molecular dynamics; Toll like receptors

Indexed keywords

ADENINE; PROTEIN BINDING; QUINOLINE; QUINOLINE DERIVATIVE; TLR7 PROTEIN, HUMAN; TLR8 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8;

ADAPTIVE IMMUNITY; ANALOGS AND DERIVATIVES; BIOLOGY; CHEMISTRY; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOLECULAR DOCKING; MOLECULAR DYNAMICS; PHYSIOLOGY; PROCEDURES; PROTEIN TERTIARY STRUCTURE;

ADAPTIVE IMMUNITY; ADENINE; COMPUTATIONAL BIOLOGY; HUMANS; IMMUNITY, INNATE; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; QUINOLINES; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8;

EID: 84929224542     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules20058316     Document Type: Article

References (85)

1. Takeda, K.; Akira, S. Toll-like receptors in innate immunity. Int. Immunol. 2005, 17, 1-14.
2. Lund, J.M.; Alexopoulou, L.; Sato, A.; Karow, M.; Adams, N.C.; Gale, N.W.; Iwasaki, A.; Flavell, R.A. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 2004, 101, 5598-5603.
3. Smits, E.L.J.M.; Ponsaerts, P.; Berneman, Z.N.; van Tendeloo, V.F.I. The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy. Oncologist 2008, 13, 859-875.
4. Triantafilou, K.; Orthopoulos, G.; Vakakis, E.; Ahmed, M.A.E.; Golenbock, D.T.; Lepper, P.M.; Triantafilou, M. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell. Microbiol. 2005, 7, 1117-1126.
5. Diebold, S.S.; Massacrier, C.; Akira, S.; Paturel, C.; Morel, Y.; Reis e Sousa, C. Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur. J. Immunol. 2006, 36, 3256-3267.
6. Chang, S.; Kodys, K.; Szabo, G. Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells. Hepatology 2010, 51, 35-42.
7. Sioud, M. Innate sensing of self and non-self RNAs by Toll-like receptors. Trends Mol. Med. 2006, 12, 167-176.
8. Schön, M.P.; Schön, M. TLR7 and TLR8 as targets in cancer therapy. Oncogene 2008, 27, 190-199.
9. So, E.Y.; Ouchi, T. The application of Toll like receptors for cancer therapy. Int. J. Biol. Sci. 2010, 6, 675-681.
10. Koski, G.K.; Czerniecki, B.J. Combining Innate Immunity with Radiation Therapy for Cancer Treatment. Clin. Cancer Res. 2005, 11, 7-11.
11. Ochi, A.; Graffeo, C.S.; Zambirinis, C.P.; Rehman, A.; Hackman, M.; Fallon, N.; Barilla, R.M.; Henning, J.R.; Jamal, M.; Rao, R.; et al. Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. J. Clin. Investig. 2012, 122, 4118-4129.
12. Magrane, M.; Consortium, U. UniProt Knowledgebase: A hub of integrated protein data. Database (Oxford) 2011, 2011, bar009.
13. Maschalidi, S.; Hässler, S.; Blanc, F.; Sepulveda, F.E.; Tohme, M.; Chignard, M.; van Endert, P.; Si-Tahar, M.; Descamps, D.; Manoury, B. Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation. PLoS Pathog. 2012, 8, e1002841.
14. Hipp, M.M.; Shepherd, D.; Gileadi, U.; Aichinger, M.C.; Kessler, B.M.; Edelmann, M.J.; Essalmani, R.; Seidah, N.G.; Reis E Sousa, C.; Cerundolo, V. Processing of Human Toll-like Receptor 7 by Furin-like Proprotein Convertases Is Required for Its Accumulation and Activity in Endosomes. Immunity 2013, 39, 711-721.
15. Iavarone, C.; Ramsauer, K.; Kubarenko, A.V.; Debasitis, J.C.; Leykin, I.; Weber, A.N.R.; Siggs, O.M.; Beutler, B.; Zhang, P.; Otten, G.; et al. A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand binding. J. Immunol. 2011, 186, 4213-4222.
16. Tanji, H.; Ohto, U.; Shibata, T.; Miyake, K.; Shimizu, T. Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands. Science 2013, 339, 1426-1429.
17. Petricevic, B.; Wessner, B.; Sachet, M.; Vrbanec, D.; Spittler, A.; Bergmann, M. CL097, a TLR7/8 ligand, inhibits TLR-4 - Dependent activation of IRAK-M and BCL-3 expression. Shock 2009, 32, 484-490.
18. Forsbach, A.; Samulowitz, U.; Völp, K.; Hofmann, H.-P.; Noll, B.; Tluk, S.; Schmitz, C.; Wader, T.; Müller, C.; Podszuweit, A.; et al. Dual or triple activation of TLR7, TLR8, and/or TLR9 by single-stranded oligoribonucleotides. Nucleic Acid Ther. 2011, 21, 423-436.
19. Jähnisch, H.; Wehner, R.; Tunger, A.; Kunze, A.; Oehrl, S.; Schäkel, K.; Rohayem, J.; Bornhäuser, M.; Tonn, T.; Bachmann, M.; et al. TLR7/8 agonists trigger immunostimulatory properties of human 6-sulfo LacNAc dendritic cells. Cancer Lett. 2013, 335, 119-127.
20. Connolly, D.J.; O'Neill, L.A.J. New developments in Toll-like receptor targeted therapeutics. Curr. Opin. Pharmacol. 2012, 12, 510-518.
21. Miller, R.L.; Meng, T.-C.; Tomai, M.A. The antiviral activity of Toll-like receptor 7 and 7/8 agonists. Drug News Perspect. 2008, 21, 69-87.
22. Kauffman, E.C.; Liu, H.; Schwartz, M.J.; Scherr, D.S. Toll-like receptor 7 agonist therapy with imidazoquinoline enhances cancer cell death and increases lymphocytic infiltration and proinflammatory cytokine production in established tumors of a renal cell carcinoma mouse model. J. Oncol. 2012, 2012, 103298, doi:10.1155/2012/103298.
23. Imiquimod - National Cancer Institute. Available online: http://www.cancer.gov/cancertopics/ druginfo/imiquimod (accessed on 19 June 2014).
24. Chang, Y.C.; Madkan, V.; Cook-Norris, R.; Sra, K.; Tyring, S. Current and potential uses of imiquimod. South. Med. J. 2005, 98, 914-920.
25. Hemmi, H.; Kaisho, T.; Takeuchi, O.; Sato, S.; Sanjo, H.; Hoshino, K.; Horiuchi, T.; Tomizawa, H.; Takeda, K.; Akira, S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002, 3, 196-200.
26. Bilu, D.; Sauder, D.N. Imiquimod: Modes of action. Br. J. Dermatol. 2003, 149 (Suppl.), 5-8.
27. Henriques, L.; Palumbo, M.; Guay, M.-P.; Bahoric, B.; Basik, M.; Kavan, P.; Batist, G. Imiquimod in the treatment of breast cancer skin metastasis. J. Clin. Oncol. 2014, 32, e22-e25.
28. Lee, J.; Chuang, T.-H.; Redecke, V.; She, L.; Pitha, P.M.; Carson, D.A.; Raz, E.; Cottam, H.B. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 2003, 100, 6646-6651.
29. Meyer, T.; Surber, C.; French, L.E.; Stockfleth, E. Resiquimod, a topical drug for viral skin lesions and skin cancer. Expert Opin. Investig. Drugs 2013, 22, 149-159.
30. Forsbach, A.; Müller, C.; Montino, C.; Kritzler, A.; Nguyen, T.; Weeratna, R.; Jurk, M.; Vollmer, J. Negative regulation of the type I interferon signaling pathway by synthetic Toll-like receptor 7 ligands. J. Interferon Cytokine Res. 2012, 32, 254-268.
31. Vultaggio, A.; Nencini, F.; Pratesi, S.; Maggi, L.; Guarna, A.; Annunziato, F.; Romagnani, S.; Parronchi, P.; Maggi, E. The TLR7 ligand 9-benzyl-2-butoxy-8-hydroxy adenine inhibits IL-17 response by eliciting IL-10 and IL-10-inducing cytokines. J. Immunol. 2011, 186, 4707-4715.
32. Weterings, J. 7-Hydro-8-oxo-adenine Derivatives as Potent TLR7 Ligands. Available online: https://openaccess.leidenuniv.nl/bitstream/handle/1887/13284/Chapter2.pdf?sequence=10 (accessed on 19 June 2014).
33. Heil, F.; Ahmad-Nejad, P.; Hemmi, H.; Hochrein, H.; Ampenberger, F.; Gellert, T.; Dietrich, H.; Lipford, G.; Takeda, K.; Akira, S.; et al. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur. J. Immunol. 2003, 33, 2987-2997.
34. Hayashi, T.; Chan, M.; Norton, J.T.; Wu, C.C.N.; Yao, S.; Cottam, H.B.; Tawatao, R.I.; Corr, M.; Carson, D.A.; Daniels, G.A. Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2. Melanoma Res. 2010, 21, 66-75.
35. Vyas, V.K.; Ukawala, R.D.; Ghate, M.; Chintha, C. Homology modeling a fast tool for drug discovery: Current perspectives. Indian J. Pharm. Sci. 2012, 74, 1-17.
36. Xiang, Z. Advances in Homology Protein Structure Modeling. Curr. Protein Pept. Sci. 2006, 7, 217-227.
37. Wei, T.; Gong, J.; Jamitzky, F.; Heckl, W.M.; Stark, R.W.; Rössle, S.C. Homology modeling of human Toll-like receptors TLR7, 8, and 9 ligand-binding domains. Protein Sci. 2009, 18, 1684-1691.
38. Wei, T.; Gong, J.; Rössle, S.C.; Jamitzky, F.; Heckl, W.M.; Stark, R.W. A leucine-rich repeat assembly approach for homology modeling of the human TLR5-10 and mouse TLR11-13 ectodomains. J. Mol. Model. 2011, 17, 27-36.
39. Yu, H.; Jin, H.; Sun, L.; Zhang, L.; Sun, G.; Wang, Z.; Yu, Y. Toll-like receptor 7 agonists: Chemical feature based pharmacophore identification and molecular docking studies. PLoS ONE 2013, 8, e56514.
40. Tseng, C.-Y.; Gajewski, M.; Danani, A.; Tuszynski, J.A. Homology and Molecular Dynamics Models of Toll-Like Receptor 7 Protein and Its Dimerization. Chem. Biol. Drug Des. 2014, 83, 656-665.
41. Amber Home Page. Available online: http://ambermd.org/ (accessed on 12 March 2015).
42. Götz, A.W.; Williamson, M.J.; Xu, D.; Poole, D.; Le Grand, S.; Walker, R.C. Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born. J. Chem. Theory Comput. 2012, 8, 1542-1555.
43. Salomon-Ferrer, R.; Götz, A.W.; Poole, D.; Le Grand, S.; Walker, R.C. Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald. J. Chem. Theory Comput. 2013, 9, 3878-3888.
44. Molecular Operating Environment (MOE), 2013.08. Available online: http://www.chemcomp.com/Research-Citing-MOE.htm (accessed on 2 February 2014).
45. Kelly, K.; Labute, P. The A∗Search and Applications to Sequence Alignment. Available online: http://www.chemcomp.com/journal/astar.htm (accessed on 10 June 2014).
46. Kelly, K. Multiple Sequence and Structure Alignment in MOE. Available online: http://www.chemcomp.com/journal/align.htm (accessed on 10 June 2014).
47. Labute, P. The generalized Born/volume integral implicit solvent model: Estimation of the free energy of hydration using London dispersion instead of atomic surface area. J. Comput. Chem. 2008, 29, 1693-1698.
48. AmberTools 12 Reference Manual. Available online: http://ambermd.org/doc12/AmberTools12.pdf (accessed on 10 March 2015).
49. Hoffmann, R. An Extended Hückel Theory. I. Hydrocarbons. J. Chem. Phys. 1963, 39, 1397, doi:10.1063/1.1734456.
50. Labute, P. Protonate 3D: Assignment of Macromolecular Protonation State and Geometry. Available online: http://www.ccl.net/cca/documents/proton/ (accessed on 31 March 2014).
51. Wang, J.; Wang, W.; Kollmann, P.; Case, D. Antechamber, An Accessory Software Package for Molecular Mechanical Calculation. J. Comput. Chem. 2005, 25, 1157-1174.
52. Wang, J.; Wolf, R.M.; Caldwell, J.W.; Kollman, P.A.; Case, D.A. Development and testing of a general amber force field. J. Comput. Chem. 2004, 25, 1157-1174.
53. Jorgensen, W.L.; Chandrasekhar, J.; Madura, J.D.; Impey, R.W.; Klein, M.L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983, 79, 926, doi:10.1063/1.445869.
54. Colovos, C.; Yeates, T.O. Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci. 1993, 2, 1511-1519.
55. Laskowski, R.A.; MacArthur, M.W.; Moss, D.S.; Thornton, J.M. PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26, 283-291.
56. Bolton, E.E.; Wang, Y.; Thiessen, P.A.; Bryant, S.H. Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities. Annu. Rep. Comput. Chem. 2008, 4, 217-241.
57. Morris, G.M.; Huey, R.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell, D.S.; Olson, A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009, 30, 2785-2791.
58. Morris, G.; Goodsell, D. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 1998, 19, 1639-1662.
59. Gasteiger, J.; Marsili, M. Iterative partial equalization of orbital electronegativity - A rapid access to atomic charges. Tetrahedron 1980, 36, 3219-3228.
60. Schrödinger Release 2013-3: LigPrep, version 2.8, Schrödinger, LLC, New York, NY. Available online: http://www.schrodinger.com/productpage/14/10/ (accessed on 24 January 2014).
61. Nussinov, R.; Wolfson, H.J. Efficient detection of three-dimensional structural motifs in biological macromolecules by computer vision techniques. Proc. Natl. Acad. Sci. USA 1991, 88, 10495-10499.
62. Wolfson, H.J.; Rigoutsos, I. Geometric hashing: An overview. IEEE Comput. Sci. Eng. 1997, 4, 10-21.
63. Corbeil, C.R.; Williams, C.I.; Labute, P. Variability in docking success rates due to dataset preparation. J. Comput. Aided Mol. Des. 2012, 26, 775-786.
64. Halgren, T.A. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 1996, 17, 490-519.
65. Halgren, T.A. MMFF VI. MMFF94s option for energy minimization studies. J. Comput. Chem. 1999, 20, 720-729.
66. Forli, S. Raccoon|AutoDock VS: An Automated Tool for Preparing AutoDock Virtual Screenings. Available online: http://autodock.scripps.edu/resources/raccoon (accessed on 7 March 2014).
67. Huey, R.; Morris, G.M.; Olson, A.J.; Goodsell, D.S. A semiempirical free energy force field with charge-based desolvation. J. Comput. Chem. 2007, 28, 1145-1152.
68. Clark, A.M. Ligand Interaction Diagrams. Available online: http://www.chemcomp.com/journal/ligintdia.htm (accessed on 27 November 2014).
69. Loncharich, R.J.; Brooks, B.R.; Pastor, R.W. Langevin dynamics of peptides: The frictional dependence of isomerization rates of N-acetylalanyl-N'-methylamide. Biopolymers 1992, 32, 523-535.
70. Berendsen, H.J.C.; Postma, J.P.M.; van Gunsteren, W.F.; DiNola, A.; Haak, J.R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984, 81, 3684.
71. Ryckaert, J.-P.; Ciccotti, G.; Berendsen, H.J. Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. J. Comput. Phys. 1977, 23, 327-341.
72. Miller, B.R.; McGee, T.D.; Swails, J.M.; Homeyer, N.; Gohlke, H.; Roitberg, A.E. MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. J. Chem. Theory Comput. 2012, 8, 3314-3321.
73. Onufriev, A.; Bashford, D.; Case, D.A. Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins 2004, 55, 383-394.
74. Onufriev, A. The Generalized Born Model: Its Foundation, Applications, and Limitations. Available online: http://people.cs.vt.edu/~onufriev/PUBLICATIONS/gbreview.pdf (accessed on 9 June 2014).
75. Kollman, P.A.; Massova, I.; Reyes, C.; Kuhn, B.; Huo, S.; Chong, L.; Lee, M.; Lee, T.; Duan, Y.; Wang, W.; et al. Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum Models. Acc. Chem. Res. 2000, 33, 889-897.
76. Genheden, S.; Kuhn, O.; Mikulskis, P.; Hoffmann, D.; Ryde, U. The normal-mode entropy in the MM/GBSA method: Effect of system truncation, buffer region, and dielectric constant. J. Chem. Inf. Model. 2012, 52, 2079-2088.
77. Jensen, F. Introduction to Computational Chemistry; John Wiley & Sons: Chicester, UK, 2013; p. 624.
78. Karplus, M.; Kushick, J.N. Method for estimating the configurational entropy of macromolecules. Macromolecules 1981, 14, 325-332.
79. Still, W.C.; Tempczyk, A.; Hawley, R.C.; Hendrickson, T. Semianalytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc. 1990, 112, 6127-6129.
80. Jayaram, B.; Liu, Y.; Beveridge, D.L. A modification of the generalized Born theory for improved estimates of solvation energies and pK shifts. J. Chem. Phys. 1998, 109, 1465, doi:10.1063/1.476697.
81. Onufriev, A.; Case, D.A.; Bashford, D. Effective Born radii in the generalized Born approximation: The importance of being perfect. J. Comput. Chem. 2002, 23, 1297-1304.
82. Onufriev, A. Chapter 7 Implicit Solvent Models in Molecular Dynamics Simulations: A Brief Overview. Annu. Rep. Comput. Chem. 2008, 4, 125-137.
83. Zhu, J.; Shi, Y.; Liu, H. Parametrization of a Generalized Born/Solvent-Accessible Surface Area Model and Applications to the Simulation of Protein Dynamics. J. Phys. Chem. B 2002, 106, 4844-4853.
84. Hou, T.; Wang, J.; Li, Y.; Wang, W. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J. Chem. Inf. Model. 2011, 51, 69-82.
85. Kommission für Technologie und Innovation KTI. Available online: http://www.kti.admin.ch/?lang=en (accessed on 15 February 2015).